3 insiders bought €1.5M of shares over the last 90 days, the latest by 임종선, filed 08 Oct 2026.
Rznomics Inc.: what insiders have been doing
Every trade that managers of Rznomics Inc. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 31 October 2026, 27 filings were filed, from 12 insiders.
On the market, 9 insiders bought (21 purchases totalling €19k) while 4 insiders sold (5 sales). The totals exclude 25 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €19k, bought by 이성욱 and made public on 16 July 2026. The buyers include 2 board members, 1 major shareholder and 1 senior executive.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 27 filings, this issuer sits above that mark. Our records for Rznomics Inc. go back to 2025, with 21 purchases and 5 sales on the open market in total.
The latest purchase dates back some time: it was published 32 days ago, on 8 October 2026. Filings reach the DART (FSS) feed a median of 7 days after the trade. This delay matters because a trade only becomes useful information once it is public.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySale+3 other insiders
Since the insiders bought
- -27.9%Entry ₩29,550 · Close 30 Oct 2026 ₩21,300
- -30.5%Entry ₩30,650 · Close 30 Oct 2026 ₩21,300
- -30.5%Entry ₩30,650 · Close 30 Oct 2026 ₩21,300
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- 25,384 sharesShareKRXDART:20261008000731Canonical exit: 6 Jan 2027 (T+90)
- 45,800 sharesShareKRXDART:20261008000727Canonical exit: 6 Jan 2027 (T+90)
- 12,935 sharesShareKRXDART:20261008000717Canonical exit: 6 Jan 2027 (T+90)
- Other0DART
- 1,000 shares@ ₩32,304.70100.0% of flowShareKRXDART:20260716000807Canonical exit: 12 Oct 2026 (T+90)
- 25,000 sharesShareKRXDART:20260710000410Canonical exit: 8 Oct 2026 (T+90)
- 25,308 sharesShareKRXDART:20260710000407Canonical exit: 8 Oct 2026 (T+90)
- 75,000 sharesShareKRXDART:20260710000404Canonical exit: 8 Oct 2026 (T+90)
- 2,245,000 sharesShareKRXDART:20260710000396Canonical exit: 8 Oct 2026 (T+90)
- 3,465,598 sharesKRXDART:20260710000342Canonical exit: 8 Oct 2026 (T+90)
- 149,874 sharesKRXDART:20260701000599
- 57,000 sharesShareKRXDART:20260619000061Canonical exit: 17 Sept 2026 (T+90)
- 20,500 sharesKRXDART:20260609000504
- 10,300 sharesKRXDART:20260410003658Canonical exit: 29 Jun 2026 (T+90)
- 252,523 sharesKRXDART:20260409002178
- 14,848 sharesKRXDART:20260401002645Canonical exit: 8 Jun 2026 (T+90)
- ●Executives0DART
- 181,489 sharesKRXDART:20260304001495
- 299,886 sharesKRXDART:20260128000359
- 25,000 sharesShareKRXDART:20251226000565Canonical exit: 29 Mar 2026 (T+90)
- 25,308 sharesShareKRXDART:20251226000567Canonical exit: 29 Mar 2026 (T+90)
- 18,000 sharesShareKRXDART:20251226000568Canonical exit: 29 Mar 2026 (T+90)
25 of 31 declarations
About Rznomics Inc.
Algenomics is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
